Durability of Response After Pausing Abrocitinib Treatment in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s600, 2025. DOI: 10.25251/gaabwz65. Disponível em: https://skin.dermsquared.com/skin/article/view/3817. Acesso em: 16 apr. 2026.